Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | AKAM | CPAY |
|---|---|---|
| Price | $105.19 | $390.60 |
| Change today | ▼ 1.09% | ▲ 0.51% |
| Market cap | $15.12B | $25.65B |
| Return, 3 months | -6.8% | – |
| Return, year to date | +20.6% | – |
| Return, 1 year | +38.7% | – |
| P/E (TTM) | 38.1 | 23.8 |
| P/B | 3.2 | 7.2 |
| P/E percentile vs own 5y | 93rd | 78th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.4% | +21.5% |
| Net profit growth (YoY) | -23.4% | -11.4% |
| Gross margin | 57.5% | 79.0% |
| Operating margin | 11.9% | 40.5% |
| Net margin | 9.5% | 22.7% |
| Return on equity | 8.9% | 30.5% |
| Analyst target vs. price | +49.2% | +20.9% |
| Analyst buy share | 59% | 83% |
| RSI (14) | 45 | – |
| 30-day volatility | 53.5% | – |
| Max drawdown, 1 year | -35.2% | – |
| Trend read | Leaning bearish | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
